ROBINS CHAD M bought ADPT

August 18, 2026 · Form 4 insider transaction

ROBINS CHAD M bought 278,676 shares of Adaptive Biotechnologies Corporation at $6.55 per share, a transaction worth $1.83M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
278,676
Price
$6.55
Total value
$1.83M
Role
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 18, 2026
Filing dateAugust 19, 2026
Shares owned after2,459,194
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR